Scheme Information
HDFC Pharma and Healthcare Reg IDCW-R
as of 07 Jun 2026, 13:21 PM
SIP Calculator
Invested Amount
₹6,00,000
Est. Return
₹5,61,695
Total Value
₹11,61,695
Scheme Ratings
rated by Value Research
Scheme Riskometer
Your principal will be at Very High Risk
Investment Returns
Absolute Returns
CAGR
Company Holdings
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Divi's Laboratories Ltd | Healthcare | E | 8.56% |
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 8.05% |
| Lupin Ltd | Healthcare | E | 6.07% |
| Glenmark Pharmaceuticals Ltd | Healthcare | E | 6.06% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 5.93% |
| Aster DM Healthcare Ltd Ordinary Shares | Healthcare | E | 5.46% |
| Alkem Laboratories Ltd | Healthcare | E | 4.69% |
| Anthem Biosciences Ltd | Healthcare | E | 4.55% |
| Ipca Laboratories Ltd | Healthcare | E | 4.39% |
| Cipla Ltd | Healthcare | E | 4.27% |
| Acutaas Chemicals Ltd | Basic Materials | E | 4.07% |
| Fortis Healthcare Ltd | Healthcare | E | 3.71% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | E | 3.04% |
| Laurus Labs Ltd | Healthcare | E | 2.80% |
| Vijaya Diagnostic Centre Ltd | Healthcare | E | 2.55% |
| Metropolis Healthcare Ltd | Healthcare | E | 2.39% |
| Global Health Ltd | Healthcare | E | 2.21% |
| Torrent Pharmaceuticals Ltd | Healthcare | E | 2.13% |
| Shilpa Medicare Ltd | Healthcare | E | 2.04% |
| Neuland Laboratories Ltd | Healthcare | E | 1.97% |
| Sai Life Sciences Ltd | Healthcare | E | 1.79% |
| Wockhardt Ltd | Healthcare | E | 1.67% |
| Eris Lifesciences Ltd Registered Shs | Healthcare | E | 1.66% |
| Rubicon Research Ltd | Healthcare | E | 1.43% |
| Jubilant Pharmova Ltd | Healthcare | E | 1.36% |
| Thyrocare Technologies Ltd | Healthcare | E | 1.33% |
| Gland Pharma Ltd | Healthcare | E | 1.02% |
| Bajaj Healthcare Ltd | Healthcare | E | 0.85% |
| Laxmi Dental Ltd | Healthcare | E | 0.59% |
| Cohance Lifesciences Ltd | Healthcare | E | 0.56% |
| Novartis India Ltd | Healthcare | E | 0.10% |
| Treps - Tri-Party Repo | - | CR | 1.91% |
| Net Current Assets | - | C | 0.79% |
| Dr. Lal PathLabs Ltd | - | E | - |
Sector Holding Analysis
Equity / Debt / Cash Split
Equity
97.29%
Cash
2.71%
Equity sector allocation
Basic Materials
4.07%
Healthcare
93.22%
Others
2.71%
Fund House Contact Details
Asset Management Company
Funds in this Category
Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
31.98%
63.78%
3Y Returns
+63.78%
Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
31.98%
63.78%
3Y Returns
+48.34%
DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
31.98%
63.78%
3Y Returns
+45.98%
About HDFC Pharma and Healthcare Reg IDCW-R
Investment Objective of the Scheme
Key Features of The Fund
5-year return
-
Fund Manager
Dhruv Muchhal
Risk Profile
Very High Risk
Expense Ratio
1.99%
Fund Size
₹2158.58 Cr
FAQ's
What is the expense ratio of HDFC Pharma and Healthcare Reg IDCW-R?
What is the AUM (Assets Under Management) of HDFC Pharma and Healthcare Reg IDCW-R?
What are the top stock holdings of HDFC Pharma and Healthcare Reg IDCW-R?
The HDFC Pharma and Healthcare Reg IDCW-R has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Divi's Laboratories Ltd | 8.56% |
| Sun Pharmaceuticals Industries Ltd | 8.05% |
| Lupin Ltd | 6.07% |
| Glenmark Pharmaceuticals Ltd | 6.06% |
| Max Healthcare Institute Ltd Ordinary Shares | 5.93% |
| Aster DM Healthcare Ltd Ordinary Shares | 5.46% |
| Alkem Laboratories Ltd | 4.69% |
| Anthem Biosciences Ltd | 4.55% |
| Ipca Laboratories Ltd | 4.39% |
| Cipla Ltd | 4.27% |
| Acutaas Chemicals Ltd | 4.07% |
| Fortis Healthcare Ltd | 3.71% |
| Krishna Institute of Medical Sciences Ltd | 3.04% |
| Laurus Labs Ltd | 2.80% |
| Vijaya Diagnostic Centre Ltd | 2.55% |
| Metropolis Healthcare Ltd | 2.39% |
| Global Health Ltd | 2.21% |
| Torrent Pharmaceuticals Ltd | 2.13% |
| Shilpa Medicare Ltd | 2.04% |
| Neuland Laboratories Ltd | 1.97% |
| Sai Life Sciences Ltd | 1.79% |
| Wockhardt Ltd | 1.67% |
| Eris Lifesciences Ltd Registered Shs | 1.66% |
| Rubicon Research Ltd | 1.43% |
| Jubilant Pharmova Ltd | 1.36% |
| Thyrocare Technologies Ltd | 1.33% |
| Gland Pharma Ltd | 1.02% |
| Bajaj Healthcare Ltd | 0.85% |
| Laxmi Dental Ltd | 0.59% |
| Cohance Lifesciences Ltd | 0.56% |
| Novartis India Ltd | 0.10% |
| Treps - Tri-Party Repo | 1.91% |
| Net Current Assets | 0.79% |
| Dr. Lal PathLabs Ltd | - |
In which sectors has HDFC Pharma and Healthcare Reg IDCW-R invested in?
The HDFC Pharma and Healthcare Reg IDCW-R has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | 4.07% |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | - |
| Healthcare | 93.22% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
What is the risk level of HDFC Pharma and Healthcare Reg IDCW-R?
Who are the fund managers of HDFC Pharma and Healthcare Reg IDCW-R?
Is there a minimum SIP amount to invest in HDFC Pharma and Healthcare Reg IDCW-R?
Can I invest in HDFC Pharma and Healthcare Reg IDCW-R both in SIP and lump sum?
How to invest in HDFC Pharma and Healthcare Reg IDCW-R?
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in HDFC Pharma and Healthcare Reg IDCW-R:
- On HDFC SKY open your demat account if you don't have one.
- Check the performance of HDFC Pharma and Healthcare Reg IDCW-R.
- Choose between SIP or Lumpsum and start your mutual fund investment journey on HDFC Sky.
Is there any exit load charges of HDFC Pharma and Healthcare Reg IDCW-R?
The exit load of HDFC Pharma and Healthcare Reg IDCW-R is as follows:
Exit load of 1.0%, if redeemed within 1 year
.What is the process to redeem my investment in HDFC SKY?
The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy